NIH – HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required)

Purpose: This funding opportunity announcement (FOA) is part of the Helping to End Addiction Long-term (HEAL) Prevention Initiative, a portfolio of research focused on the prevention of opioid misuse and…

NIH: Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)

Purpose: This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for…

HEAL Initiative: Coordinated Pain Care in Health Care Systems Research Program – Coordinating Center (U24 Clinical Trial Not Allowed)

Purpose: The purpose of this FOA is to solicit applications for a Coordinating Center to provide leadership for the HEAL Coordinated Approaches to Pain Care in Health Care Systems Program.…

ARVO Foundation: Kreissig Award for Excellence in Retinal Surgery

Purpose: This award, established by Ingrid Kreissig, MD in 2020 with an endowment through the ARVO Foundation, recognizes the next generation of curious, enterprising investigators who seek to optimize functional…

Melanoma Research Alliance

Purpose: The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity Request for Proposals (RFP) for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising…

NIH – Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing the development and/or validation of targeted mass spectrometric assays (e.g. Multiple Reaction Monitoring) for proteins and peptides of primary…